A study by Thybusch-Bernhardt et al. suggested that HER1 and HER2 overexpression contributes to a more aggressive phenotype and that lack of HER4 expression may increase the metastatic capacity of pancreatic cancer cells [34]. Here, ERBB2 is linked to familial pancreatic carcinoma.